Prostaglandin inactivation is increased in endometrium after exposure to clomiphene.
Prostaglandin (PG) dehydrogenase inactivates PGs by oxidising the 15-hydroxyl group and thus plays a key role in controlling their effective local concentrations. This enzyme is thought to be under the control of steroid hormones and is found in human endometrium at high levels in the secretory phase of the menstrual cycle but is absent during the proliferative phase. We have examined the PG dehydrogenase activity in human endometrium from women who had been treated with the anti-oestrogen clomiphene at an earlier stage of the cycle and found high levels of the enzyme in the proliferative phase. This data was supported by the culture of endometrium from clomiphene treated women which showed both high PG production and extensive inactivation comparable to that seen in the secretory phase. This effect of clomiphene on the PG inactivating ability of endometrium could be of clinical use in management of disorders where elevated PGs are present.
Kelly
R W
RW
Medical Research Council Reproductive Biology Unit, University of Edinburgh Centre for Reproductive Biology, Scotland.
Linan
C
C
Thong
J
J
Yong
E L
EL
Baird
D T
DT
D000328:Adult; D002996:Clomiphene / Q000494:pharmacology*; D046508:Culture Techniques; D004717:Endometrium / Q000187:drug effects* / Q000378:metabolism*; D004790:Enzyme Induction / Q000187:drug effects; D005260:Female; D005498:Follicular Phase / Q000378:metabolism; D006801:Humans; D006911:Hydroxyprostaglandin Dehydrogenases / Q000096:biosynthesis; D008183:Luteal Phase / Q000378:metabolism; D011448:Prostaglandin Antagonists / Q000378:metabolism*; D011458:Prostaglandins E / Q000378:metabolism; D013997:Time Factors
D011448:Prostaglandin Antagonists; D011458:Prostaglandins E; D002996:Clomiphene; D006911:Hydroxyprostaglandin Dehydrogenases